Skip to content
Open access · CC-BY via OpenAlex

Senolytic treatment with dasatinib and quercetin selectively improves cardiac autonomic balance in obesity

Mahesh Kumar Sivasubramanian, Raisa Monteiro, Joshua Thomas Butcher, UdayKiran Venugopal, Yasodha Kesavan, Priya Balasubramanian, Madhan Subramanian

GeroScience · 2026 · ▲ 1 citations

Abstract

Chronic sympathetic nerve activity (SNA) to end organs plays a crucial role in the pathophysiology of obesity-induced hypertension. Oxidative stress and neuroinflammation in the rostral ventrolateral medulla (RVLM), a key brainstem region regulating sympathetic outflow, have been implicated in the sympathetic overactivity in obesity. However, the upstream mechanisms driving RVLM neuroinflammation remain unknown. We hypothesized that obesity induces cellular senescence(definition), a stress response characterized by irreversible cell cycle arrest, in the RVLM and contributes to sympathoexcitation. To test this, C57BL/6 J male mice were fed chow or a high-fat diet (HFD) for 16 weeks, followed by treatment with Dasatinib (5 mg/kg) and Quercetin (50 mg/kg) (D + Q) to selectively eliminate senescent cells. Blood pressure was assessed by radiotelemetry in conscious, freely moving mice. SNA was indirectly measured through heart rate variability (HRV) analysis, depressor response to hexamethonium, and serum norepinephrine levels. The RVLM was microdissected for gene expression and protein analysis of senescence markers and DNA damage. Our results showed that HFD mice had a significant increase in mean arterial pressure and SNA compared to chow-fed controls. Obesity was associated with increased DNA damage and upregulation of cellular senescence markers in the RVLM. Senolytic treatment with D + Q selectively improved cardiac autonomic balance as assessed by HRV, without altering indices of global SNA or blood pressure. Collectively, our findings identify cellular senescence in the RVLM as a novel contributor to obesity-induced sympathoexcitation, and senolytic therapy could be a potential therapeutic avenue for obesity-associated autonomic dysfunction.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1007/s11357-026-02289-6
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Sivasubramanian, M.K., Monteiro, R., Butcher, J.T., Venugopal, U., Kesavan, Y., Balasubramanian, P., &amp; Subramanian, M. (2026). Senolytic treatment with dasatinib and quercetin selectively improves cardiac autonomic balance in obesity. <em>GeroScience</em>. https://doi.org/10.1007/s11357-026-02289-6
Vancouver
Sivasubramanian MK, Monteiro R, Butcher JT, Venugopal U, Kesavan Y, Balasubramanian P, et al. Senolytic treatment with dasatinib and quercetin selectively improves cardiac autonomic balance in obesity. GeroScience. 2026. doi:10.1007/s11357-026-02289-6.
BibTeX
@article{mahesh2026Senoly, title = {Senolytic treatment with dasatinib and quercetin selectively improves cardiac autonomic balance in obesity}, author = {Mahesh Kumar Sivasubramanian and Raisa Monteiro and Joshua Thomas Butcher and UdayKiran Venugopal and Yasodha Kesavan and Priya Balasubramanian and Madhan Subramanian}, journal = {GeroScience}, year = {2026}, doi = {10.1007/s11357-026-02289-6}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings